Page last updated: 2024-08-23

ursodeoxycholic acid and Cell Transformation, Neoplastic

ursodeoxycholic acid has been researched along with Cell Transformation, Neoplastic in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (66.67)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fickert, P; Halilbasic, E; Moustafa, T; Trauner, M1
Cheng, E; Huo, X; Juergens, S; Meyer, F; Rezaei, D; Souza, RF; Spechler, SJ; Strauch, ED; Wang, DH; Wang, JY; Yu, C; Zhang, Q; Zhang, X1
Alberts, DS; Fang, C; Lance, P; Smith, JW; Thompson, PA; Wertheim, BC1
Fujiyama, S; Hirokawa, S; Masaki, T; Miyakawa, K; Ohkawa, S; Tamai, S; Tanaka, K; Tarao, K1
Cao, M; Hanski, C; Hanski, ML; Jahreis, G; Keller, S; Loddenkemper, C; Stein, H; Zeitz, M1
Arber, N; Boursi, B1

Reviews

2 review(s) available for ursodeoxycholic acid and Cell Transformation, Neoplastic

ArticleYear
Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseases.
    Wiener medizinische Wochenschrift (1946), 2008, Volume: 158, Issue:19-20

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Sub-Family B Member 4; Bile; Bile Acids and Salts; Bile Canaliculi; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cell Transformation, Neoplastic; Cholangiocarcinoma; Cholangitis, Sclerosing; Cholestasis, Intrahepatic; Cholic Acids; Disease Models, Animal; Humans; Liver Neoplasms; Mice; Mice, Knockout; Mutation; Norsteroids; Ursodeoxycholic Acid

2008
Current and future clinical strategies in colon cancer prevention and the emerging role of chemoprevention.
    Current pharmaceutical design, 2007, Volume: 13, Issue:22

    Topics: Alcohol Drinking; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Barium Compounds; Cell Transformation, Neoplastic; Chemoprevention; Colonoscopy; Colorectal Neoplasms; Contrast Media; Diet; Early Diagnosis; Enema; Exercise; Genetic Testing; Hormone Replacement Therapy; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Life Style; Mass Screening; Occult Blood; Patient Compliance; Risk Assessment; Risk Factors; Sigmoidoscopy; Smoking; Ursodeoxycholic Acid

2007

Trials

1 trial(s) available for ursodeoxycholic acid and Cell Transformation, Neoplastic

ArticleYear
Risk modification of colorectal adenoma by CYP7A1 polymorphisms and the role of bile acid metabolism in carcinogenesis.
    Cancer prevention research (Philadelphia, Pa.), 2012, Volume: 5, Issue:2

    Topics: Adenoma; Aged; Cell Transformation, Neoplastic; Cholesterol 7-alpha-Hydroxylase; Colorectal Neoplasms; Double-Blind Method; Feces; Female; Humans; Male; Polymorphism, Single Nucleotide; Prognosis; Risk Factors; Ursodeoxycholic Acid

2012

Other Studies

3 other study(ies) available for ursodeoxycholic acid and Cell Transformation, Neoplastic

ArticleYear
Deoxycholic acid causes DNA damage while inducing apoptotic resistance through NF-κB activation in benign Barrett's epithelial cells.
    American journal of physiology. Gastrointestinal and liver physiology, 2011, Volume: 301, Issue:2

    Topics: Aged; Analysis of Variance; Animals; Apoptosis; Barrett Esophagus; Cell Line; Cell Transformation, Neoplastic; Deoxycholic Acid; DNA Damage; Epithelial Cells; Histones; Humans; I-kappa B Proteins; Male; Middle Aged; NF-kappa B; NF-KappaB Inhibitor alpha; Rats; Reactive Nitrogen Species; Reactive Oxygen Species; Signal Transduction; Ursodeoxycholic Acid

2011
Ursodiol use is possibly associated with lower incidence of hepatocellular carcinoma in hepatitis C virus-associated liver cirrhosis.
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2005, Volume: 14, Issue:1

    Topics: Alanine Transaminase; Analysis of Variance; Carcinoma, Hepatocellular; Cell Transformation, Neoplastic; Cholagogues and Choleretics; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Glycyrrhizic Acid; Hepacivirus; Hepatitis C; Humans; Incidence; Inflammation; Liver Cirrhosis; Liver Neoplasms; Logistic Models; Male; Middle Aged; Risk Factors; Treatment Outcome; Ursodeoxycholic Acid

2005
Prevention of colitis-associated carcinogenesis in a mouse model by diet supplementation with ursodeoxycholic acid.
    International journal of cancer, 2006, Jun-01, Volume: 118, Issue:11

    Topics: Administration, Oral; Animals; Bile Acids and Salts; Carcinoma; Cell Transformation, Neoplastic; Cholagogues and Choleretics; Colitis; Colon; Colorectal Neoplasms; Diet; Disease Models, Animal; Female; Mice; Mice, Inbred C57BL; Ursodeoxycholic Acid

2006